A case of false positive octreoscan in Crohn's disease
Sunday, September 21, 2008 - 12:14
in Biology & Nature
Neuroendocrine tumors, such as carcinoid tumors, overexpress somatostatin receptors in their membranes. Octreotide is an analogue whose molecule is a shortened version of somatostatin's with a high affinity for these receptors. The labelled form of octreotide is able to be imaged in scans (Octreoscan) and, therefore, pathological conditions overexpressing somatostatin receptors are easily recognized in this technique. Specifically, in the case of the detection of carcinoid tumors, the Octreoscan has sensitivity nearly to 90%.
Read the whole article on Physorg
More from Physorg
Related
- A case of false positive octreoscan in Crohn's diseaseSun, 21 Sep 2008, 13:16:28 EDT
- A new Eph receptor tyrosine kinase overexpressed in gastric cancer was foundThu, 30 Oct 2008, 8:23:14 EDT
- JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumorThu, 9 Jul 2009, 16:32:03 EDT
- Doctors can unmask deceptive high-risk breast tumors using genetic profileWed, 21 May 2008, 16:14:53 EDT
- Turned-off cannabinoid receptor turns on colorectal tumor growthFri, 1 Aug 2008, 12:14:50 EDT